Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-12-038691
Filing Date
2012-07-09
Accepted
2012-07-09 16:19:47
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v317969_10ka.htm 10-K/A 32443
2 EXHIBIT 31.1 v317969_ex31-1.htm EX-31.1 11074
3 EXHIBIT 31.2 v317969_ex31-2.htm EX-31.2 11862
4 EXHIBIT 32.1 v317969_ex32-1.htm EX-32.1 6040
5 EXHIBIT 32.2 v317969_ex32-2.htm EX-32.2 6108
  Complete submission text file 0001144204-12-038691.txt   4564578

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rxpc-20111231.xml EX-101.INS 1101775
7 XBRL TAXONOMY EXTENSION SCHEMA rxpc-20111231.xsd EX-101.SCH 23959
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxpc-20111231_cal.xml EX-101.CAL 34178
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxpc-20111231_def.xml EX-101.DEF 80296
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxpc-20111231_lab.xml EX-101.LAB 178468
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxpc-20111231_pre.xml EX-101.PRE 109339
Mailing Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780
Business Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780 7145054460
RADIENT PHARMACEUTICALS Corp (Filer) CIK: 0000838879 (see all company filings)

EIN.: 330413161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16695 | Film No.: 12953542
SIC: 2834 Pharmaceutical Preparations